PATENT CLAIM ANALYSIS

Application Number: 16381557
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-10
Patent Classification: ["424", "093200"]

Abstract:
The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a transglutaminase (TGM) polypeptide (e.g., a Transglutaminase-1 (TGM1) polypeptide); viruses comprising the recombinant nucleic acids; compositions comprising the recombinant nucleic acids and/or viruses; methods of their use; and articles of manufacture or kits thereof.

Claim (Index 24):
The method of  claim 23 , wherein the recombinant HSV-1 genome comprises an inactivating mutation in a herpes simplex virus gene selected from the group consisting of Infected Cell Protein (ICP) 0, ICP4, ICP22, ICP27, ICP47, thymidine kinase (tk), Long Unique Region (UL) 41, and UL55.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.55263
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15393151', '16177153', '15851488', '11166438', '10766897']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7930129144163168
- 35 USC 102 Novelty (BERT): 0.6002775772718796
- Combined Prediction Score: 0.7737393807018731
- Mean Citation Score: 443.620332
- Max Citation Score: 520.2533
- Similarity Product: 471.6612068529725

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test